Article
- Author:
- Bruce Jancin
Publish date: October 25, 2016
VIENNA – The combination of methylphenidate and psychotherapy, be it group or individual, is now the best evidence-based treatment strategy i...
Article
- Author:
- Bruce Jancin
Publish date: October 24, 2016
ROME – The novel oral anticoagulants are now strongly recommended over warfarin for stroke prevention.
Article
- Author:
- Bruce Jancin
Publish date: October 24, 2016
VIENNA – Modafinil shows early promise for the treatment of cognitive dysfunction in patients with remitted depression.
Article
- Author:
- Bruce Jancin
Publish date: October 21, 2016
VIENNA – Adding low-dose ketamine to standard anesthesia for ECT does not reduce treatment-associated cognitive impairment or speed antidepre...
Article
- Author:
- Bruce Jancin
Publish date: October 20, 2016
ROME – Mortality is high following surgical aortic valve replacement in patients with radiation-induced severe aortic stenosis, and STS score...
Article
- Author:
- Bruce Jancin
Publish date: October 19, 2016
VIENNA – Tildrakizumab, a novel biologic for moderate to severe psoriasis, showed favorable efficacy and safety outcomes in two pivotal phase...
Article
- Author:
- Bruce Jancin
Publish date: October 18, 2016
VIENNA – Secukinumab showed reassuring safety with no drop-off in efficacy for psoriasis after 4 years of treatment.
Article
- Author:
- Bruce Jancin
Publish date: October 18, 2016
ROME – Beta-blocker therapy significantly reduces the risks of cardiac death and all-cause mortality, but not sudden death, in heart failure ...
Article
- Author:
- Bruce Jancin
Publish date: October 16, 2016
Don’t prescribe warfarin for patients with calciphylaxis.
Article
- Author:
- Bruce Jancin
Publish date: October 16, 2016
Hope for interventions to prevent childhood atopic dermatitis hinges on ongoing studies of home water softeners, maternal probiotic intake, and int...
Article
- Author:
- Bruce Jancin
Publish date: October 15, 2016
Interleukin-13 appears to be a central mediator in atopic dermatitis, and the investigational biologic lebrikizumab effectively blocks it.
Article
- Author:
- Bruce Jancin
Publish date: October 14, 2016
VIENNA – A once-daily topical anticholinergic agent called DRM04 achieved positive outcomes for the treatment of primary axillary hyperhidros...
Article
- Author:
- Bruce Jancin
Publish date: October 12, 2016
VIENNA
Article
- Author:
- Bruce Jancin
Publish date: October 12, 2016
VIENNA - Paternal use of systemic immunosuppressive agents in the months prior to conception didn't result in increased risk of preterm birth, ...
Article
- Author:
- Bruce Jancin
Publish date: October 11, 2016
VIENNA – Cariprazine appears to improve predominant negative symptoms of schizophrenia.
